We identified a tendency of direct correlation between the expression of the mTOR gene RPS6 and the expression of the mesenchymal marker ZEB1 in two different cohorts (TCGA and CGGA cohorts), suggesting a link between the mTOR pathway and EMT in GBM patient samples. This evidence concerns the gene RPS6 and glioblastoma.